Peloton Therapeutics

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Launch date

2010

Market cap

Enterprise valuation

€909m (Public information from May 2019)

Dallas Texas (HQ)

Date	Investors	Amount	Round
Jul 2011	The Column Group Remeditex Ventures	$18.0m	Series A
Sep 2016	The Column Group Foresite Capital Remeditex Ventures Nextech Invest	$52.4m	Series D
Mar 2017	The Column Group Foresite Capital Remeditex Ventures Nextech Invest	$22.2m	Series D
Feb 2019	OrbiMed Eventide Asset Management RA Capital Management Vida Ventures Curative Ventures EcoR1 Capital Driehaus Capital Management	$150m	Series E
May 2019	Merck	$1.0b Valuation: $1.0b	Acquisition
Total Funding		€221m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Peloton Therapeutics